Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Vaccine|May 31, 2022
Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaquesMasanori Shiohara, Saori Suzuki, Shintaro Shichinohe, et al.
The Journal of General Virology|March 20, 2025
NEDD4-binding protein 1 suppresses hepatitis B virus replication by regulating viral RNAsNobuhiro Kobayashi, Saori Suzuki, Yuki Sakamoto, et al.
Elife|April 23, 2021
SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formationDavid W Sanders, Chanelle C Jumper, Paul J Ackerman, et al.
Vaccine|March 13, 2019
Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenzaToshiki Sekiya, Edin J Mifsud, Marumi Ohno, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Liver-specific Mettl14 deletion induces nuclear heterotypia and dysregulates RNA export machineryKeith A Berggren, Saloni Sinha, Aaron E Lin, et al.
NPJ Vaccines|June 11, 2025
Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicityLiudmila Kulakova, Kiki H Li, Austin W T Chiang, et al.
Immunology and Cell Biology|August 3, 2020
Immune profiling of influenza-specific B- and T-cell responses in macaques using flow cytometry-based assaysMarios Koutsakos, Toshiki Sekiya, Brendon Y Chua, et al.
Vaccine|June 6, 2021
Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cellsMasashi Shingai, Naoki Nomura, Toshiki Sekiya, et al.
Nature Communications|February 8, 2024
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variantTomokazu Tamura, Takashi Irie, Sayaka Deguchi, et al.
Ebiomedicine|June 5, 2024
Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236Shigeru Fujita, Arnon Plianchaisuk, Sayaka Deguchi, et al.
Pageof 8